Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer
Clinical trial NCT03532087 · WITHDRAWN
Trial details
- NCT number
- NCT03532087
- Sponsor
- Borstkanker Onderzoek Groep
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2021-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.